Home › Funds › Logan Stone Capital, LLC › DMII
Logan Stone Capital, LLC position in DMII
DRUGS MADE IN AMERICA ACQUISITION II CORP · Financials
Logan Stone Capital, LLC reported holding 381,686 shares of DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP) in its Q2 2026 13F filing — a position valued at US$3.8M, representing 0.81% of its reported portfolio and ranking #20 among its reported holdings. Logan Stone Capital, LLC has disclosed DMII holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Logan Stone Capital, LLC's DMII position evolved
Logan Stone Capital, LLC first disclosed a stake in DMII in Q1 2026 at 11,313 shares (US$113K). The position peaked in Q2 2026 at 381,686 shares, worth US$3.8M. Across 2 filings, Logan Stone Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 381,686 shares valued at US$3.8M — an increase of 370,373 shares quarter over quarter.. Notable position changes include a 3274% increase in Q2 2026 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 11.31K | $112.79K | New |
| Q2 2026 | 381.69K | $3.84M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DMII and 13F data
DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP) is a Financials company. 70 other funds we track also report a position in DMII — the largest reported positions include Karpus Management, Inc. (US$28.0M), Magnetar Financial LLC (US$27.2M), MMCAP International Inc. SPC (US$27.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DMII
- Karpus Management, Inc. 2.79M sh · $28.05M · Q2 2026
- Magnetar Financial LLC 2.70M sh · $27.16M · Q2 2026
- MMCAP International Inc. SPC 2.70M sh · $27.16M · Q2 2026
- GLAZER CAPITAL, LLC 2.34M sh · $23.57M · Q2 2026
- HIGHBRIDGE CAPITAL MANAGEMENT LLC 2.24M sh · $22.57M · Q2 2026
- WOLVERINE ASSET MANAGEMENT LLC 1.86M sh · $18.66M · Q2 2026
- Crossingbridge Advisors, LLC 1.10M sh · $11.07M · Q2 2026
- First Trust Capital Management L.P. 1.07M sh · $10.74M · Q2 2026
- Mercuria Capital Strategies, LLC 750.00K sh · $7.54M · Q2 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 519.40K sh · $5.23M · Q2 2026
- TIG Advisors, LLC 500.00K sh · $5.03M · Q2 2026
- Wealthspring Capital LLC 400.44K sh · $4.03M · Q2 2026
More on Logan Stone Capital, LLC
FAQ
How long has Logan Stone Capital, LLC held DMII?
Logan Stone Capital, LLC has disclosed DMII holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Logan Stone Capital, LLC's current position in DMII?
As of Q2 2026, Logan Stone Capital, LLC holds 381.69K shares of DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP), valued at $3.84M, representing 0.81% of its reported portfolio and ranking #20.
Has Logan Stone Capital, LLC been buying or selling DMII?
In the latest 13F filing (Q2 2026), Logan Stone Capital, LLC increased its position in DMII. The position peaked in Q2 2026 at 381.69K shares.
Which other funds hold DMII?
Other major institutional holders of DMII include Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.